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Background 
 
Abstract 
Most humans infected with Mycobacterium tuberculosis (M.tb) can exhibit asymptomatic 
control of the infection however, 10% of humans can reactivate infection to develop contagious 
tuberculosis (TB). IL-10 is an immunosuppressive cytokine that has been hypothesized to play a 
role in the reactivation of M.tb infection. Previous studies have shown that CBA/J IL10 knockout 
mice can better control M.tb infection compared to wild type CBA/J mice. This has been noted 
by a measured decrease in the pulmonary bacterial load throughout infection, an increase in 
survival compared to M.tb-infected CBA/J mice, and enhanced early TH1 mediated immune 
responses. Multifunctional CD4+ T cells, T cells that produce IFN-γ, TNF-α, and IL-2, have 
recently been linked to control of M.tb infection. The goal of this project was to analyze 
multifunctional T cells in the CBA/J mouse strain, a strain that is naturally susceptible to M.tb, as 
well as in CBA/J IL-10 knockout mice. The mediastinal lymph node of CBA/J mice and CBA/J 
IL10 knockout mice was analyzed early in infection for the presence of multifunctional CD4+ T 
cells. Our hypothesis was the IL-10 knockout mice would show higher numbers of T cells as 
well as more T cells with the ability to produce multiple pro-inflammatory cytokines at early 
time points in infection. It was found that the CBA/J IL10 knockout mice possessed more CD4+ 
T cells with the ability to produce one, two, or three of the protective cytokines. Therefore, the 
presence of multifunctional CD4 T cells may be linked with improved control of M.tb infection, 
a finding that could lead to further therapeutic development.  
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Introduction 
Tuberculosis Prevalence in the World 
Nearly one-third of the world’s population is infected with Mycobacterium tuberculosis 
(M.tb). According to the CDC, in 2010, there were 8.8 million people who developed 
tuberculosis and 1.5 million TB-related deaths worldwide (1). In 2010, 5.7 million new and 
recurrent TB cases were being treated (2).  Officially classified as a “disease of poverty,” by the 
World Health Organization (WHO), 95% of TB deaths are in the developing world (2).  In the 97 
countries that count for this percentage of TB deaths, it expected that financing TB care and 
control would amount to US$ 4.4 billion dollars in 2012 (2). TB is currently the leading cause of 
death for people who are infected with human immunodeficiency virus (HIV) (1). In the African 
region, where TB is the most prevalent, 44% of TB patients also test HIV-positive, and the WHO 
considers TB and HIV to be global co-epidemics.  
TB remains a global epidemic, and while there have been decreasing absolute numbers of 
infected individuals since 2006 (2), infection is estimated to occur at the rate of one person per 
second, leading research efforts on M.tb to achieve an incredible importance (3).  
 
Reactivation of Latent M.tb Infection  
M.tb is a slow-growing facultative, intracellular pathogen transmitted primarily by the 
respiratory route, leading to pulmonary infection in 85% of humans who develop the disease (4). 
However, infection does not usually lead to active disease. The pathogen has evolved to avoid 
destruction by both innate and adaptive immunity and to induce lung pathology, exemplified by 
a classically defined granuloma (5).  The granuloma succeeds in allowing for containment rather 
than elimination of the pathogen, and can usually allow for the infected individual to remain 
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asymptomatic and noninfectious for their entire life (5). However, about 5-10% of the infected 
individuals revert from clinical latency of M.tb and develop reactivated tuberculosis (TB).  
 
The mouse as a model for M. tb susceptibility 
Mouse tuberculosis is a model of tuberculosis for susceptible humans, classified by their 
inability to resolve infection and prevent disease (5). The immunology of mouse TB is similar in 
important ways to human TB and is currently used to investigate key questions about the disease 
(5). Resistance and susceptibility to M.tb infection can be modeled in mice, with the CBA/J 
mouse modeling relative susceptibility to M.tb due to its increased pulmonary bacterial load and 
decreased survival when compared to the resistant C57BL/6 mouse strain (7). The CBA/J mouse 
can be characterized by its increased production of interleukin-10 (IL-10) during late stages of 
chronic TB infection (7). IL-10 is a potent immunosuppressive cytokine that affects innate and 
acquired immune responses, and in M.tb, is thought to promote disease progression. One of the 
targets of IL-10 via macrophages is Th1-type CD4+ immunity, specifically the inhibition of pro-
inflammatory cytokines interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF), and 
interleukin-2 (IL-2), leading to reduced protective immunity in M.tb infection (8). It is important 
to note that IL-10 has been identified as a correlate of susceptibility for tuberculosis in humans 
(9). Due to the fact that the absence of IL-10 leads to improved control of M.tb infection, a 
CBA/J IL-10 deficient mouse provides a model of protection from TB susceptibility.  
 
The Importance of IL-10 Early in M.tb Infection   
 The CBA/J IL-10-/- mouse shows a very strong protected phenotype at late time points in 
M.tb infection when compared to the CBA/J mouse (unpublished data). This has been 
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demonstrated through decreased bacterial load in the lungs of CBA/J IL-10-/- mice beginning as 
early as day 60 post infection (unpublished data). Additionally, the IL-10 knockout shows 
improved granuloma formation in comparison with the CBA/J granuloma, which is generally 
observed to be a macrophage dominated and disorganized lesion (8). In the absence of IL-10, 
CBA/J mice form compact, leukocyte-rich, mature granulomas. These granulomas are 
characterized by necrotic centers and cuffing of CD4+ T cells as well as the presence of collagen, 
an indication of fibrosis (unpublished observation).  
Although the CBA/J IL10-/- mouse demonstrates control of M.tb infection at late time 
points, it is of interest to discover the earliest possible period of time post infection that IL-10 
absence affects the immune response. IL-10 is thought to inhibit host antimicrobial mechanisms 
early in infection  and it is known that in the absence of IL-10 there are enhanced levels of IFN-γ 
in the lung early during infection, which can lead to increased M.tb killing controlled by an 
IFNγ-mediated activation of macrophages via reactive oxygen and nitrogen intermediates (10). 
IL-10 also blocks phagosome maturation, allowing for M.tb growth and survival, and may have a 
role in blocking antigen presentation through downregulation of major histocompatibility 
molecules (10).  In recent studies, our lab has discovered that blocking IL-10 receptor for the 
first 21 days of infection leads to decreased bacterial load in the CBA/J mouse as determined at 
day 120 of infection (unpublished observation).  
Th1 Immunity and Multifunctional T cells  
 Anti-M.tb immunity in mice is considered to be Th1 mediated, mediated predominantly 
by CD4 Th1 cells with the assistance of CD8 T cells (4). Past studies have indicated that the 
protective role of CD4 and CD8 T cells is based on their ability to secrete key Th1 cytokines to 
activate macrophages at infection sites (5). While it has been shown that Th1-type CD4+ and 
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cytokines are necessary for M.tb protection, they do not serve as a correlate of protection against 
M.tb (12).  Interferon-gamma (IFN-γ), is a cytokine critical in protection against bacterial 
intracellular pathogens, but neither in humans nor in mice does the frequency of IFN-γ cells 
correspond to protection (12). IFN-γ, produced by both CD4 and CD8 T cells, is necessary but 
not sufficient for protection against M.tb. TNF, secreted by macrophages, dendritic cells, and T 
cells, is also believed to play complex and important roles in immune and pathologic response in 
tuberculosis through macrophage activation in synergy with IFN-γ (4).  
 Recently, there have been studies showing the importance of T cells with complex 
phenotypic and polyfunctional cytokine-secreting profiles, including a group that co-expresses 
IFN-γ, TNF, and IL-2 (13). In humans, vaccination with modified Vaccinia virus Ankara 
expressing Ag85A (MVA85A), a dominant M.tb antigen, induces T cells with this complex, 
triple-cytokine producing profile (13).  Additionally, multifunctional T cells secreting IFN-γ, 
TNF, and IL-2 have been shown to correlate with protection from other parasitic infections in 
mice, such as Leishmania major (14). It is thought that combined analysis of different cytokines 
coexpressed by multifunctional T cells can differentiate between TB patients and patients with 
latent TB, invoking the idea that quality rather than quantity of Mtb-specific T cell response 
generates protection and long term memory (12).  
 
Development of the Adaptive Immune Response in Mediastinal  Lymph Node in Mtb infection 
 In the host cell, M.tb modulates early innate immune responses and delays the onset of 
adaptive immune response (4). This results in a delay in activation of CD4+ T cells in the local 
lung-draining mediastinal lymph node (11). In mice, the earliest antigen-specific CD4+ T cell 
response in the MLN is noted 12 days post aerosol infection (15).  
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 In further characterization of the development of adaptive immunity in Mtb infection, it 
has been found that activation of T cells is the limiting step in the development of the adaptive 
immune response and after proliferation in the lymph node, CD4+ effector T cells move rapidly 
to the lungs (11). Therefore, in order to gauge the earliest possible T cell response to Mtb, it is 
necessary to analyze the T cell populations within the MLN during the first few weeks of 
infection.   
 
Multifunctional T cells in the Mediastinal Lymph Node (MLN) Early in M.tb Infection 
 In this study, we considered the CBA/J IL-10-deficient mouse to be a model of protective 
TB. Considering the importance of IL-10 early in infection, we analyzed the numbers of T cells 
and cytokine profile of those T cells present in the lymph node during early time points post 
infection in both CBA/J and CBA/J IL10-/- mice. We specifically looked for the presence of T 
cells producing IFN-γ, TNF, and IL-2 in any combination. We proposed a two-pronged 
hypothesis that in the CBA/J IL10-/- mice, (A) there would be more T cells as well as more 
activated T cells present in the MLN at early time points post infection and (B) there would 
be more multifunctional, cytokine producing T cells in the MLN. Using flow cytometry, we 
analyzed the T cells present in the MLN from days 10 to 31 of M.tb infected CBA/J and CBA/J 
IL10-/- mice, staining both for activation surface markers and intracellular cytokines.  
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Materials and Methods 
Tissue Culture Media: 1 bottle 500 ml Dulbecco’s Modification of Eagle’s Media 
(Cellgro/Fisher MT15-017-CV), containing 10 ml minimal essential amino acids (Sigma 
M7145), 5 ml HEPES buffer (Sigma H0887), 5 ml L-glutamine (Sigma G7513), 5 ml 
Penicillin/Streptomycin (Sigma P0781), 660 µl 2-mercaptoethanol (50mM), and 45 ml heat 
inactivated fetal bovine serum (Atlas F-0500-D, Lot A20530B). 
 
Gey’s Solution: 4.15g NH4Cl (8mM), 0.5g KHCO3 (5mM), 500 ml bottled LPS free H20, sterile 
filtered. 
 
10X PBS: 2.56g NaH2PO4·H20, 22.49g Na2HPO4·7H20, 87.66g NaCl, QS to 1 liter with ddH20. 
 
10X PBST: 2.56g NaH2PO4·H20, 22.49g Na2HPO4·7H20, 87.66g NaCl, 5 ml Tween 20, QS to 1 
liter with ddH20. 
 
Deficient RPMI (dRPMI): 10.10g RPMI-1640 (Cellgro 90-022-PB), 10.42 ml HEPES (Sigma 
H0887), QS to 1 liter in ddH20. pH to 7.4, sterile filter and add 1g/L of sodium azide.  
 
Aerosol: M.tb Erdman (ATCC no. 35801) was obtained from American Type Culture Collection. 
Stocks were grown according to published methods. Mice were infected with M.tb Erdman using 
an inhalation exposure system (Glas-Col) calibrated to deliver 50–100 CFU to the lungs of each 
mouse. 
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Mice: CBA/J mice (National Cancer Institute, Frederick, MD) were crossed with C57BL/6 IL-
10-/- mice (Jackson laboratories, Bar Harbor, Maine) for eight generations. At each cross 
progeny were earpunched and DNA was screened for the presence of a neomycin cassette at the 
il10 gene locus and IL-10+/- mice were selected for further breeding. At the eighth generation, 
heterozygotes were crossed and IL-10-deficient homozygote CBA/J mice were selected. A 
homozygous breeder colony of CBA/J IL-10-/- mice was maintained thereafter. 
Specific pathogen-free, age/sex-matched CBA/J IL-10-/- and CBA/J wild-type (NCI) were 
maintained in ventilated cages inside a biosafety level 3 (BSL3) facility and provided with sterile 
food and water ad libitum. All protocols were approved by The Ohio State University’s 
Institutional Laboratory Animal Care and Use Committee.  
At specific time points, mice were euthanized by CO2 asphyxiation in accordance with 
Institutional Animal Care and Use Committee protocol.  
 
Single Cell Suspension 
The mediastinal lymph node from CBA/J and CBA/J IL10-/- mice were gently passed through a 
70 µm cell strainer (BD Falcon) to form a single cell suspension. Cell suspensions were 
equalized to 5 ml using tissue culture media (TCM) and centrifuged for 7 min at 1,200 rpm at 
4°C. The supernatant was poured off and the cell pellet was resuspended. Gey’s Solution (2 ml) 
was added for 3 min at room temperature to lyse the red blood cells. The reaction was quenched 
by adding 8 ml TCM. The cell suspension was centrifuged for 7 min at 1,200 rpm at 4°C. The 
supernatant was discarded and the cell pellet was resuspended in 1 ml of TCM. 
Cells were added to Trypan blue in a 1:10 dilution in order to count viable cells.  
The cells were counted using a hemacytometer and adjusted to equal concentrations at each 
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experimental time point.  
 
Intracellular Flow Cytometry 
From the single cell suspension, 500 µl of cells were plated in a 24 well plate. The cells were 
crosslinked for 4 hours at 37ºC with 250 µl of anti-CD3, anti-CD28, and BD GolgiStop™ 
Protein Transport Inhibitor (at concentrations noted in Table 1). The cells were then fixed in 
equal volume of dRPMI. Then, 200 µl of cells were transferred to a 96 well plate, centrifuged for 
7 min at 1,200 rpm at 4°C, the supernatant was decanted, and the cells were resuspended in 100 
µl dRPMI. The cells were spun and the supernatant decanted a second time, but resuspended in 
BD Fc Block at 12.5 µg/mL (BD Biosciences) and incubated for 20 minutes at at 4°C. The 
fluorochrome-conjugated anti-cytokine antibodies for CD3, CD4, and CD8 were added to the 
cells (at concentrations that can be noted in Table 2) and incubated for another 20 minutes at 
4°C. The cells were permeabilized with a Cytofix/Cytoperm fixation/permeabilization solution 
kit from BD Biosciences and cytokines IFN-γ, TNF, and IL-2 were stained using fluorochrome 
conjugated antibodies (at concentrations that can be noted in Table 3). 
 
Preparation of Surface Stains for Flow Cytometry 
The cells remaining from the single cell suspension were added to an equal volume of dRPMI, 
plated at 200 µl per well into 96 well plate, and centrifuged for 7 min at 1,200 rpm at 4°C. The 
supernatant was decanted and the cells were resuspended in 100 µl dRPMI. The cells were spun 
and the supernatant decanted a second time, but the cells were resuspended in BD Fc Block (BD 
Biosciences) and incubated for 20 minutes at at 4°C. The surface stains for anti-CD3, anti-CD4, 
and anti-CD8 were added to the cells (at concentrations that can be noted in Table 2) and 
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incubated for another 20 minutes at at 4°C. The cells were then washed twice in dRPMI, 
resuspended in 200 µl of dRPMI and read using a LSRII flow cytometer and analyzed with 
FACSDiva Sofware (BD Biosciences). Lymphocytes were gated according to their forward and 
side scatter profiles and the CD4+ and CD8+ T cells were gated based on the presence of CD4 or 
CD8 and CD3. The populations of CD4+ and CD8+ T cells were further analyzed using surface 
marker and cytokine expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Flow Cytometry Gating 
This is representative of the gating using in the flow cytometry analysis on BD FACSDiva. The top left 
image shows a forward and side scatter profile and gating of lymphocytes. The top right image shows 
CD4+ T cells, a population of cells with CD4 expression (PE-Cy7-A) and CD3 expression (PerCP-CY5.5-
A). The bottom image shows CD4+ T cells that are expressing a level of CD69 (APC-A) that exceeds the 
isotype control. 
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Data Analysis and Statistics: Flow cytometry data was converted from percentages to absolute 
numbers using a percentage hierarchy developed in FACSDiva Softare and a spreadsheet in 
Microsoft Excel (Microsoft Office, Redmond, WA). Statistical significance was determined 
using the Prism 4 software (GraphPad Software, San Diego, CA). The unpaired two-tailed 
Student t test was used for comparisons of CBA/J and CBA/J IL10-/- mice. 
Table 1. Antigens Used in Crosslinking 
Antigen Used  Company Catalog Number Concentration 
Anti-CD3 eBioscience 16-0031-86 10µg/mL 
Anti-CD28 eBioscience 16-0281-86 1 µg/mL 
Golgi Stop™ BD Biosciences 554724 as directed in kit 
 
Table 2. Surface Stains 
Surface Marker Company Catalog Number Concentration 
PerCP-Cy5.5 anti-CD3e BD Biosciences 551163 12.5 µg/mL 
PE-Cy7 anti-CD4 BD Biosciences 552775 12.5 µg/mL 
Allophycocyanin-Cy7 anti-CD8 BD Biosciences 557654 12.5 µg/mL 
Allophycocyanin anti-CD69 BD Biosciences 560689 12.5 µg/mL 
FITC anti-CD25 BD Biosciences 553072 12.5 µg/mL 
 
Table 3. Intracellular Stains 
Cytokine Company Catalog Number Concentration 
PE-Cy7 anti-IFNγ BD Biosciences 554413 12.5 µg/mL 
PerCP-Cy5.5 anti-TNF BD Biosciences 560659 12.5 µg/mL 
PE anti-IL-2 BD Biosciences 554428 12.5 µg/mL 
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Results 
1. Analysis of T Cell Number in MLN in CBA/J (WT) and CBA/J IL10-/- Mice 
The mediastinal lymph node (MLN) was collected from CBA/J (wild type) and CBA/J 
IL10-/- (knockout) mice at days 10, 15, 18, 24, and 31 post infection. The MLN was made into a 
single cell suspension and the cells were divided among surface flow cytometry, and intracellular 
flow cytometry. The phenotypic surface markers CD3, CD4, and CD8 were tagged with 
fluorescently labeled antibodies and analyzed via flow cytometry to determine total numbers of 
T cells present in the MLN. The data of CBA/J mice reflects a group of 4 mice and the data for 
the CBA/J IL-10-/- mouse reflects a group of 5 mice analyzed individually. These experiments 
were repeated twice to assess experimental variability. In both CBA/J and the CBA/J  IL10-/- 
mice, the total number of T cells increased as the infection progressed (Figure 1). By day 31, the 
CBA/J IL10-/- mice averaged 9.0x107 T cells in the lymph node, while in the CBA/J mice had 
only about 50% of the number of T cells present in the knockout mice, 4.5x107 T cells at day 31 
This result did not achieve significance due to large experimental variation, most likely 
associated with MLN collection methods. 
 
 
Figure 1. T cells in the MLN of CBA/J 
and CBA/J IL10-/- mice 
Mediastinal  lymph node cells from CBA/J 
and CBA/J IL10-/- mice were analyzed by 
flow cytometry. Cells were gated 
according to their forward and side scatter 
profiles and expression of CD3. Data 
represents 4-5 mice per group per time 
point and is representative of 2 
experiments. Statistical analysis was 
performed via the unpaired Student’s t test. 
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The proportions and total numbers of CD4+ T cells were subsequently analyzed. 
Throughout the time points measured, the CD4+ T cells of both the wild type and knockout mice 
rose from slightly more than 20% at day 10 to 35% of the total T cell population within the MLN 
by day 31 (Figure 2a). The populations of CD4+ T cells (Figure 2b) remained equivalent in both 
mouse strains. The populations of both wild type and knockout mice CD4+ T cells increased 
throughout the experiment, showing 150% growth in number from day 24 to 31. The percentage 
of CD8+ T cells did not differ significantly throughout the experiment. The CD8+ T cells 
accounted for 20% of the total T cells in the CBA/J mice at day 10 post infection and 25% of the 
T cells present in the MLN of CBA/J IL10-/- mice at the same time point (Figure 3a). However, 
by day 31 post infection, the CD8+ T cells only accounted for 20% of the total T cells present in 
both mouse strains. The CD8+ T cells (Figure 3b) present in the MLN consistently remained 
under 5x106 throughout the experiment, until the final time point of day 31. At day 31, the 
knockout CD8+ T cell population rose to 1.25x107 while the wild type mice averagely achieved 
7.5x106 CD8+ T cells in the MLN. From analysis of CD8+ T cell percentages and absolute 
numbers, there were no significant differences between the wild type and the knockout mice. 
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Figure 2. CD4+ T cells in MLN of CBA/J and CBA/J IL10-/- mice. The cell numbers are expressed in 
(A) percentage and (B) absolute numbers of T cells present. 
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of both CD3 and CD4. Data represents 
4-5 mice per group per time point and is representative of 2 experiments. Statistical analysis was performed via the 
unpaired Student’s t test. 
 
 
 
 
  
 
 
Figure 3. CD8+ T cells in MLN of CBA/J and CBA/J IL10-/- mice. The cell numbers are expressed in 
(A) absolute numbers of T cells present and (B) percentage. 
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of both CD3 and CD8. Data represents 
4-5 mice per group per time point and is representative of 2 experiments. Statistical analysis was performed via the 
unpaired Student’s t test. 
 
 
 
 
B. 
A. B. 
 
A. 
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2. T Cell Activation, measured by CD69 and CD25 Surface Markers on T Cells, in the MLN 
CD69, an early T cell activation marker, was determined on T cells. In percentage 
analysis, day 10 post infection showed an equivalent activation of CD4+ T cells in both strains of 
33.4% for the wild type mice and 34.7% for the knockout mice (Figure 4a). From day 15 through 
the end of the experiment, both the wild type and knockout mice show a decrease in activated 
CD4+ T cells to 8.2% for the wild type mice and 10.2% for the IL-10 knockout. Among CD4+ T 
cells, both CBA/J and CBA/J IL10-/- mice showed increasing numbers of activated cells in the 
time points measured post infection (Figures 4b). While the CBA/J IL10-/- mice had a trend for 
more CD69 expression on days 24 (average of 1.3x105 cells) and 31 (average of 2.5x106 cells) 
when compared to CBA/J mice on the same days (5.2x105 and 1.4x106 cells), it was not a 
significant difference. The percentages of CD8+ T cells in both the wild type and the knockout 
MLN show an overall decrease from day 10 to 31 (Figure 5a).The CD8+ T cells of both mouse 
strains show no discernable pattern of activation throughout the experiment, largely remaining at 
low levels, below 2.5x105, days 10-31 (Figure 5b).   
A. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. CD69+ CD4+T cells in MLN of CBA/J and CBA/J IL10-/- mice. In (A) the CD4+ T cells with 
the CD69 activation marker are expressed in percentage and (B) shows the absolute numbers. 
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4, and CD69. Data 
represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical analysis was 
performed via the unpaired Student’s t test. 
B. 
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Figure 5. CD69+ CD8+ T cells in MLN of CBA/J and CBA/J IL10-/- mice. In (A) the CD8+ T cells with 
the CD69 activation marker are expressed in absolute numbers and (B) shows the percentage. 
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD8, and CD69. Data 
represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical analysis was 
performed via the unpaired Student’s t test 
 
CD25, the receptor for IL-2, a cytokine causing T cell proliferation was also determined. 
Both CD4+ and CD8+ T cells were found to have consistently low expression of CD25 
throughout the early time points of the experiment (Figures 6a and 6b). In the CD4+ T cell 
population, the CD25+ cells increased equivalently in both mouse strains at day 24. The IL-10 
knockout mice MLN contained 1x105 more CD25+ CD4+ T cells by day 31, however this was not 
a significant increase. The CD25+ CD8+ T cells remained at very low levels throughout the entire 
experiment in both mouse strains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. B. 
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Figure 6. CD25+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that are 
expressing CD25 and (B) shows the CD8 T cells expressing CD25.  
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 6A) or CD8 (in 6B), 
and CD25. Data represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical 
analysis was performed via the unpaired Student’s t test 
 
 
3. CBA/J IL-10-/- mice show higher levels of CD4+ T cell cytokine production in the mediastinal 
lymph node.  
The MLN cells used for intracellular flow cytometry were analyzed for 
multifunctionality, or capability of producing any combination of the pro-inflammatory 
cytokines IFN-γ, TNF-α, and IL-2. Cells used for intracellular flow cytometry were labeled on 
the surface for the phenotypic markers CD3, CD4 and CD8 and then were permeabilized and 
stained intracellularly for the cytokines of interest.  
Single Positive T cells  
In the population of CD4+ T cells that could produce IFN-γ, the IL-10 knockout mice 
showed a consistent increase throughout the experiment. The CBA/J CD4+ T cells positive for 
IFN-γ also increased throughout the experiment, but in a more stepwise manner (Figure 8a). By 
day 31, the IL-10 knockout mice MLN contained an average of 1.0x105 more IFN-γ positive 
cells (2.4x105 cells in the knockout compared to 1.4x105 cells in the wild type).  The CD8+ T 
cells that stained positive for IFN-γ production remained equivalent in both mouse strains in the 
B. A. 
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early time points of the experiment. However, after day 24, there was a split in the numbers of 
CD8+ T cells producing IFN-γ, with the knockout mice containing 1.5x105 more IFN-γ CD8+ T 
cells than the wild type. By day 31, the T cells capable of producing IFN-γ in the knockout mice 
were continuing to increase while the wild type mouse showed a plateau (Figure 7A) or decrease 
(Figure 7B) in the IFN-γ+ T cell populations.  
 
 
 
 
 
Figure 7. IFN- + T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that are 
expressing IFN-  and (B) shows the CD8 T cells expressing IFN- .  
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 7A) or CD8 (in 7B), 
and IFN-γ. Data represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical 
analysis was performed via the unpaired Student’s t test 
 
The second cytokine analyzed was tumor necrosis factor-α (TNF). Of the three cytokines 
analyzed (IFN-γ, TNF, and IL-2), at the conclusion of the experiment, TNF was expressed by the 
largest number of cells. Until day 18, there were very few CD4+ T cells producing TNF in the 
MLN in both mice strains. After day 18, both the wild type and the knockout mice showed a 
marked increase in TNF+ CD4+ T cells and day 31 showed the knockout mice with 1.25x106 
more CD4+ T cells that are expressing TNF (Figure 8a). Compared to the CD4+ T cells, the CD8+ 
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T cells in both strains of mice produce very little TNF throughout the entire experiment, 
remaining at 5.0x105 cells or less from day 10 to day 31 (Figure 8b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. TNF+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that are 
expressing TNF and (B) shows the CD8 T cells expressing TNF.  
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 8A) or CD8 (in 8B), 
and TNF. Data represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical 
analysis was performed via the unpaired Student’s t test 
 
 The third cytokine that was analyzed in this experiment was IL-2. The numbers of cells 
staining positively for IL-2 varied extensively throughout the experiment for both CD4+ and 
CD8+ T cells. For CD4+ T cells, there were no significant differences between the wild type and 
the knockout mice during the course of the experiment. Both strains of mice peaked in number of 
CD4 T cells producing IL-2 at day 24, with 3.75x105 IL-2+ CD4+ T cells in the wild type mice 
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and 3.0x105 IL-2+ CD4+ T cells in the knockout mice (Figure 9a).  Compared to the CD4+ T cells 
expressing IL-2, relatively few CD8+ T cells stained positively for IL-2. Throughout the 
experiment, both wild time and knockout mice MLN contained IL-2+ CD8+ T cells in numbers 
less than or equal to 5.0x104 (Figure 9b). 
 
Figure 9. IL-2+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that are 
expressing IL-2 and (B) shows the CD8 T cells expressing IL-2.  
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 9A) or CD8 (in 9B), 
and IL-2. Data represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical 
analysis was performed via the unpaired Student’s t test 
 
 Double Positive T cells  
 The T cells in the MLN were also analyzed for the ability to produce two or three 
cytokines. These T cells are considered multifunctional, and were the T cells of greatest interest 
in this study. The first double positive T cells analyzed were expressers of IFN-γ and TNF. In 
both the wild type and the knockout, the number of IFN-γ and TNF expressing CD4+ T cells 
remained constant until day 18, increased to about 1x105 at day 24 and then the wild type mice 
showed a slight decrease in the cell population to 5.4x104 cells and the knockout mice more than 
doubled the number of IFN-γ+ TNF+ CD4+ T cells to 2.7x105 cells. Compared to the CD4+ T 
cells, the CD8+ T cells that were double positive for IFN-γ and TNF remained at low levels. The 
number of cells of both mice strains remained below 1x105 throughout the entire experiment.  
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Figure 10. IFN + TNF+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that 
are expressing IFN  and TNF (B) shows the CD8 T cells expressing IFN  and TNF. 
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 10A) or CD8 (in 
10B), IFN-γ, and TNF. Data represents 4-5 mice per group per time point and is representative of 2 experiments. 
Statistical analysis was performed via the unpaired Student’s t test 
 
 The second population of double positive cells in the MLN that were analyzed was IFN-
γ+ IL-2+ T cells. Most likely due to the variability in IL-2 expression in the T cells, this double 
positive population showed variability throughout the time points as well. The CD4+ CBA/J T 
cells expressing both IFN-γ and IL-2 remained below 1x104 cells for the entire experiment. 
However, the IL-10 knockout mice showed almost a 10 fold increase from averaging 1.9x104 
cells at day 18 to averaging 1.8x105 cells at day 24 and maintained the difference at day 31. In 
the IFN-γ+ IL-2+ CD8+ T cell population, the cell numbers in both mouse strains remained at low 
levels, below 1x104 cells, until day 24, when the IFN-γ+ IL-2+ CD8+ T cells in the knockout mice 
spiked at 3.7x104. The corresponding cells from the CBA/J mice remained at 1.2x104 for days 24 
and 31.  
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Figure 11. IFN + IL-2+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that 
are expressing IFN  and IL-2 (B) shows the CD8 T cells expressing IFN  and IL-2.  
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 11A) or CD8 (in 
11B), IFN-γ, and IL-2. Data represents 4-5 mice per group per time point and is representative of 2 experiments. 
Statistical analysis was performed via the unpaired Student’s t test 
 
 
 
The third and final population of double positive T cells that were analyzed was CD4+ 
and CD8+ T cells that expressed TNF and IL-2. As with the majority of the double positive cells, 
the TNF+ IL-2+ CD4+ T cells remained at very low levels until after day 18. After day 18, both 
mouse strains showed consistent increase in cell numbers of TNF+ IL-2+ CD4+ T cells. The 
knockout showed a greater number of cells at days 24 and 31 than the wild type mice; however 
the difference was not significant (Figure 12a). At days 24 and 31, the knockout mice averaged 
1.5x105 and 2.1x105 cells while the wild type averaged 3.3x104 and 1.4x105 cells. The CD8+ T 
cells expressing TNF and IL-2 remained at low numbers throughout the experiment when 
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compared to CD4+ T cells of the same cytokine profile. The cell numbers in the MLN for both 
mouse strains are at or below 5x104 throughout the entire experiment.  
 
 
 
 
 
Figure 12. TNF+ IL-2+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice. (A) Shows the CD4 T cells that 
are expressing TNF and IL-2 (B) shows the CD8 T cells expressing TNF and IL-2. 
Mediastinal lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4 (in 12A) or CD8 (in 
12B), TNF, and IL-2. Data represents 4-5 mice per group per time point and is representative of 2 experiments. 
Statistical analysis was performed via the unpaired Student’s t test 
 
 
 
 
Triple Positive T cells  
 The final cytokine profile that was analyzed was the T cells positive for IFN-γ, TNF, and 
IL-2.This measurement was only able to be taken accurately at day 24. The triple expresser 
CD4+ T cells were more numerous in the IL-10 knockout mouse, averaging 1.0x105 compared to 
A. B. 
26	  
	  
the wild type mouse, which averaged 3.5x104. The triple expressing CD8+ T cells were present in 
very low numbers for both IL-10 knockout mice and wild type mice. The IL-10 knockout mice 
averaged 1.2x103 cells and the wild type mice averaged 1.3x103 (Figure 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. IFN + TNF+ IL-2+ T cells in the MLN of CBA/J and CBA/J IL10-/- mice at day 24 post infection. 
Figure 13 shows the CD4 T cells that are expressing IFN , TNF, and IL-2, and the CD8 T cells expressing 
IFN , TNF, and IL-2. 
Mediastinal  lymph node cells from CBA/J and CBA/J IL10-/- mice were analyzed by flow cytometry. Cells 
were gated according to their forward and side scatter profiles and expression of CD3, CD4  or CD8, IFN-γ, TNF, 
and IL-2. Data represents 4-5 mice per group per time point and is representative of 2 experiments. Statistical 
analysis was performed via the unpaired Student’s t test 
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Discussion 
Tuberculosis is a disease that affects millions of people in the world. One of the most 
puzzling aspects of TB is why some people develop active TB while others are able to contain 
the bacteria and keep the disease in a latent state. In studies using the CBA/J IL10-/- mouse 
model of protection from reactivation and the CBA/J model of susceptibility to reactivation, we 
have the ability to further explore the reactivation phenotype.  
This project provides a preliminary analysis of the T cell profile within the mediastinal 
lymph node of CBA/J and CBA/J IL-10 deficient mice at early points in M.tb infection. We 
hypothesized that IL-10 deficient CBA/J mice would show increased numbers T cells in the 
MLN and that those T cells would have increased cytokine profiles. In this study, we show that 
while the numbers of total, CD4+, and CD8+ T cells in the MLN did not vary significantly 
throughout the experiment, the CD4+ T cells in the IL-10 deficient mice showed greater ability to 
produce one, two, or three cytokines. In the knockout mice, CD4+ T cells showed trends of 
greater production of T cells expressing single cytokines IFN-γ, TNF, and IL-2 and expressing 
double cytokines IFN-γ/TNF, TNF/IL-2, and IFN-γ /IL-2.  Additionally, the knockout mice 
showed trends of increased T cells expressing IFN-γ, TNF, and IL-2.  
The CBA/J IL-10-/- mice are protected in M.tb infection. Additionally, when there is early 
depletion of IL-10 in the CBA/J mouse, there is better control of infection, noted in both 
decreased bacterial burden in the lungs and organized, mature granuloma formation (unpublished 
data). Therefore, IL-10 is implicated in affecting early immune response to M.tb.  
The lung-draining mediastinal  lymph node is thought to be the site of M.tb adaptive 
response initiation (11). In accordance with the literature, a significant presence of antigen-
specific T cells in the MLN isn’t noted until 10-12 days post infection (15, 17). Throughout early 
M.tb infection, we observed increasing numbers of T cells and specifically CD4+ T cells in the 
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MLN in the wild type and the IL10-/- mice, indicating the early proliferation of T cells. However, 
we did not observe increased numbers of CD4+ T cells in the IL10-/- mice as has been previously 
noted (16). Based on our observations of T cell number and expression of early activation marker 
CD69, there was no acceleration of T cell activation in the MLN in the absence of IL-10. 
Although we did not note increased acceleration or activation of T cells in IL10-/- mice, 
we did measure an increase in multifunctional T cells, CD4+ T cells capable of producing one, 
two or three cytokines. Currently, there are contradictory views on the role of multifunctional T 
cells in relation to M.tb infection. Multifunctional T cells have been correlated with active M.tb 
infection in human peripheral blood mononuclear cells as well as with protection against M.tb 
infection in mice (12,14). These contradictory findings could be due to differences in 
experimental models. Our findings are in agreement with previous mouse models that suggest a 
greater number of multifunctional T cells in mice that are protected in M.tb infection (14). 
Multifunctional T cells have been studied in additional pathogens and past studies of elevated 
numbers of multifunctional T cells HIV and Leishmania major infection (12) support the idea 
that multifunctional T cells correlate with protection against intracellular pathogens.  
While trends of increased cytokine production in the IL10-/- mice were observed in this 
experiment, statistical significance was often not achieved. This was most likely due to technical 
challenges in excising MLN at early time points as well as inconsistencies in MLN size among 
mice used. A repeat experiment with increased technique expertise could lead to significance in 
these trends. The multifunctional T cells needs to be further analyzed in M.tb infection to 
accurately assess if multifunctional T cells are responsible for control of infection. An adoptive 
cell transfer of multifunctional T cells into the CBA/J mouse could provide a further link to 
identify if multifunctional T cells could recover the protected phenotype. 
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In summary, we show that the absence of IL-10 does not lead to an early or enhanced T 
cell response in the MLN of CBA/J mice. We suggest that increased numbers of double and 
triple cytokine producing, multifunctional T cells are present in the IL10-/- mouse and that these 
cells may play a role in increased protection in M.tb infection.  
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